JNJ Jan 2024 120.000 put
| Previous Close | 1.9800 |
| Open | 1.8700 |
| Bid | 1.7500 |
| Ask | 2.1700 |
| Strike | 120.00 |
| Expire Date | 2024-01-19 |
| Day's Range | 1.8700 - 1.8700 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 2.27k |
- Motley Fool
3 Surprisingly Underrated Stocks to Buy in April
Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE) as opportunities that especially stand out. Prosper Junior Bakiny (Axsome Therapeutics): Last year, Axsome Therapeutics' share price doubled, partly due to the FDA approving its depression medicine Auvelity for use. The company's stock is down by 19% since the start of the year.
- Reuters
UPDATE 2-Johnson & Johnson unit loses bid to stay in bankruptcy during Supreme Court appeal
A Johnson & Johnson company cannot delay a court order dismissing its bankruptcy, a U.S. court said on Friday, despite the company's planned Supreme Court appeal to use bankruptcy to resolve tens of thousands of lawsuits over its talc products. J&J sought to use the bankruptcy of its subsidiary company, LTL Management, to halt more than 38,000 lawsuits alleging the company's Baby Powder and other talc products are contaminated with asbestos. J&J maintains its consumer talc products are safe and asbestos-free.
- Reuters
Johnson & Johnson unit loses bid to stay in bankruptcy during Supreme Court appeal
(Reuters) -A Johnson & Johnson company cannot delay a court order dismissing its bankruptcy, a U.S. court said on Friday, despite the company's planned Supreme Court appeal to use bankruptcy to resolve tens of thousands of lawsuits over its talc products. J&J sought to use the bankruptcy of its subsidiary company, LTL Management, to halt more than 38,000 lawsuits alleging the company's Baby Powder and other talc products are contaminated with asbestos. J&J maintains its consumer talc products are safe and asbestos-free.
